Human IgG4 Isotype Control Antibody

CAT#: MOB-0408ZL

Recombinant Human IgG4 monoclonal antibody specifically binds to a hapten that is not expressed in mammalian cells.

Tested Data
Figure 1 Human IgG4 Isotype Control Antibody (MOB-0408ZL) in SDS-PAGE

Specifications

  • Immunogen
  • Hapten molecule not expressed in mammalian cells
  • Host Species
  • Human
  • Type
  • Human IgG4, κ
  • Clone
  • FU015
  • Applications
  • ELISA, IB, FC, IHC, FuncS

Product Property

  • Purification
  • Affinity chromatography purified.
  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Format
  • Liquid
  • Concentration
  • 1.0 mg/ml
  • Buffer
  • 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <0.01 EU/µg of the protein (<0.001 ng/µg of the protein) as determined by the LAL test.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IGHG4; immunoglobulin heavy chain constant region gamma 4
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for MOB-0408ZL. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression David Walker
09.Sep,23
Excellent for IgG4 Control
The Human IgG4 Isotype Control Antibody has been excellent for our IgG4 control studies. Its specificity and sensitivity are top-notch, providing clear and reliable results. This antibody has significantly improved the accuracy of our experiments and saved us a lot of troubleshooting time.
Breast cancer biomarkers at key points during disease progression Emily Turner
11.Oct,22
Reliable in Immunoassays
We incorporated this antibody into our immunoassays, and it has been a great asset. The specificity for IgG4 is precise, allowing for accurate detection and analysis. The reliable performance has made it an invaluable tool in our lab.
Breast cancer biomarkers at key points during disease progression John Harris
20.Jul,21
Consistent and High-Quality
This antibody has proven to be consistent and high-quality in our assays. The reproducible results and strong affinity for IgG4 have significantly improved our experiments, making it a crucial part of our research toolkit. The consistent performance has greatly enhanced our data quality.

Q&As

  1. Is the Human IgG4 isotype control antibody suitable for use in flow cytometry?

    A: Yes, the Human IgG4 isotype control antibody (MOB-0408ZL) is suitable for use in flow cytometry. It provides an appropriate control for determining the level of non-specific binding in flow cytometry assays.

  2. What are the storage recommendations for the Human IgG4 isotype control antibody?

    A: The recommended storage condition for the Human IgG4 isotype control antibody (MOB-0408ZL) is at -20°C or lower. For short-term storage, it can be kept at 2-8°C. To ensure stability, avoid repeated freeze-thaw cycles.

  3. Can the Human IgG4 isotype control antibody be used in immunoprecipitation assays?

    A: Yes, the Human IgG4 isotype control antibody (MOB-0408ZL) can be used in immunoprecipitation assays. It provides an appropriate control for determining the level of non-specific binding in such assays.

  4. Is the Human IgG4 isotype control antibody effective in ELISA applications?

    A: Yes, the Human IgG4 isotype control antibody (MOB-0408ZL) is effective in ELISA applications. It provides an appropriate control for determining the level of non-specific binding in ELISA assays.

  5. What is the optimal dilution for using the Human IgG4 isotype control antibody in immunofluorescence?

    A: The optimal dilution for using the Human IgG4 isotype control antibody (MOB-0408ZL) in immunofluorescence is typically 1:100 to 1:500. It is advisable to perform a dilution series to determine the best working concentration for your specific experimental conditions.

View the frequently asked questions answered by Creative Biolabs Support.

Citations

  1. Choi, Seong Jin, et al. "KIR+ CD8+ and NKG2A+ CD8+ T cells are distinct innate-like populations in humans." Cell Reports 42.3 (2023). https://doi.org/10.1016/j.celrep.2023.112236
    This study explores the heterogeneity among human KIR+CD8+ and NKG2A+CD8+ T cells, identifying them as distinct innate-like populations with different cytokine responsiveness. The research demonstrates that KIR+CD8+ T cells exhibit IL-15-induced NK-like cytotoxicity, while NKG2A+CD8+ T cells show IL-12/IL-18-induced IFN-gamma production. It was observed that KIR+CD8+ T cells are more terminally differentiated and replicative senescent compared to NKG2A+CD8+ T cells, which are more responsive to IL-12 and IL-18 due to the high expression of these receptors induced by the transcription factor PLZF.
    At Creative Biolabs, we provided essential reagents for this study, including the anti-NKG2A antibody (Cat#: TAB-437CQ) and the IgG4 isotype control (Cat# MOB-0408ZL) used in the flow cytometry analyses. Our products were crucial in identifying the distinct functional roles and cytokine responses of these T cell subsets. This research underscores the importance of understanding the diverse functions of T cell populations in developing targeted immunotherapies, highlighting our commitment to advancing immunological research and innovative therapeutic solutions.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# MOB-0408ZL, RRID: AB_3111477)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare